
### [Orphanet:102024](http://www.orpha.net/ORDO/Orphanet_102024)
**Label:** Human herpesvirus 8-related disorder

**Subclasses:** [Orphanet:33276](http://www.orpha.net/ORDO/Orphanet_33276) (Kaposi sarcoma), [Orphanet:160](http://www.orpha.net/ORDO/Orphanet_160) (Castleman disease), 

**Corr. equiv. classes:** [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), [Orphanet:33276](http://www.orpha.net/ORDO/Orphanet_33276), [Orphanet:160](http://www.orpha.net/ORDO/Orphanet_160), 

**Class expressions from DL-Learner:**

- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0200035](http://purl.obolibrary.org/obo/HP_0200035) (Skin plaque) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0200034](http://purl.obolibrary.org/obo/HP_0200034) (Papule) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0100742](http://purl.obolibrary.org/obo/HP_0100742) (Vascular neoplasm) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 66.67%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 66.67%


